Pipeline

OVERVIEW

Our current pipeline consists of new molecular entities with relevant mechanism of actions in skin diseases, targeting significant market opportunities in the global dermatology market.

PIPELINE

PRODUCT
CANDIDATE
MOA &
INDICATION
PRE-
CLINICAL
PHASE
1
PHASE
2a
PHASE
2b
PHASE
3
Sofpironium
Bromide
Retrometabolically designed topical anticholinergic for primary axillary hyperhidrosis

Title

44%
Early Research Programs
Targeting various skin diseases

Title

7%
HELPFUL RESOURCES FOR PATIENTS